Cargando…
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
The transcription factor nuclear factor-κB (NF-κB) plays a complicated role in multiple tumors. Mounting evidence demonstrates that NF-κB activation supports tumorigenesis and development by enhancing cell proliferation, invasion, and metastasis, preventing cell death, facilitating angiogenesis, reg...
Autores principales: | Wu, Xuesong, Sun, Liang, Xu, Fangying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302521/ https://www.ncbi.nlm.nih.gov/pubmed/37375731 http://dx.doi.org/10.3390/ph16060783 |
Ejemplares similares
-
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
por: Rauch, Daniel A., et al.
Publicado: (2021) -
Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018) -
Molecular targets in arthritis and recent trends in nanotherapy
por: Roy, Kislay, et al.
Publicado: (2015) -
Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies
por: Xu, Jiangmei, et al.
Publicado: (2022) -
Oxygen‐Independent Sulfate Radical for Stimuli‐Responsive Tumor Nanotherapy
por: Ding, Dandan, et al.
Publicado: (2022)